Showing results (391-400 of 831) with videos related to

Sort By:
Pageof 84
Cancer|August 12, 2006
Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experienceApostolia-Maria Tsimberidou, Susan O'Brien, Hagop M Kantarjian, et al.
Cancer|December 13, 2006
Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
British Journal of Haematology|March 8, 2007
Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictorsGautam Borthakur, Susan O'Brien, William G Wierda, et al.
Cancer|July 11, 2008
Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitorsDan Jones, Deborah Thomas, C Cameron Yin, et al.
Cancer|October 2, 2010
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulating factorJorge Cortes, Alfonso Quintás-Cardama, Dan Jones, et al.
Cancer|February 8, 2006
Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposalJorge E Cortes, Moshe Talpaz, Susan O'Brien, et al.
Blood|April 16, 2008
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemiaConstantine S Tam, Susan O'Brien, William Wierda, et al.
Cancer|October 31, 2002
Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromesAlvaro Aguayo, Hagop M Kantarjian, Elihu H Estey, et al.
Cancer|September 16, 2003
Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemiaJorge Cortes, Moshe Talpaz, Susan O'Brien, et al.
Cancer|October 20, 2011
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Tait D Shanafelt, Neil E Kay, Kari G Rabe, et al.
Pageof 84